Innovation Pharmaceuticals Inc (IPIX)

[Rdunn88]

Trial costs increased 60 percent from 2008 until 2013... Phase 3 is the most costly of the phases... So, expect any estimate (by company) to be a conservative amount. 30 million could easily be much more in a few years...

http://www.cuttingedgeinfo.com/press-release/as-early-stage-clinical-trial-costs-rise-late-stage-costs-level-off/

Data from the latest Cutting Edge Information study, “Clinical Development and Trial Operations: Protocol Design and Cost Per Patient Benchmarks,” found that costs have nearly doubled in five years, with the average Phase 3b trial now costing $48,500 per-patient. While pivotal studies saw a dramatic cost increase between 2008 and 2011, new data indicate that per-patient costs in Phase 3 trials have leveled off in 2013.